For the Inventor, By the Inventor

Enter assignee name

Bengaluru, India

Advinus Therapeutics Private Limited

USPTO Granted Patents = 15

% Expired Patents = 13.3

EPO Patents = 9

Trademarks = 1

Forward Citations = 85

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Dinesh Barawkar (7 out of 10 patents)

Debnath Bhuniya (6 out of 15 patents)

Kasim A Mookhtiar (6 out of 6 patents)

4. Yogesh Waman (6 out of 7 patents)

5. Sujay Basu (6 out of 12 patents)

6. Venkata Poornapragnacharyulu Palle (6 out of 106 patents)

7. Summon Koul (5 out of 6 patents)

8. Vidya Ramdas (5 out of 11 patents)

9. Meena Patel (4 out of 10 patents)

10. Anil Panmand (4 out of 7 patents)

11. Santosh Kurhade (3 out of 3 patents)

12. Robert Zahler (2 out of 74 patents)

13. Anil M Deshpande (2 out of 3 patents)

14. Umesh Singh (2 out of 11 patents)

15. Partha Mukhopadhyay (2 out of 2 patents)

15 patents: Sort by Forward Citations

1. 10435402 - Bicyclic compounds, compositions and medicinal applications thereof (2019-10-08),

2. 9682953 - Amide compounds, compositions and applications thereof (2017-06-20),

3. 9593115 - Substituted fused tricyclic compounds, compositions, and medicinal applications thereof (2017-03-14),

4. 9550793 - Spirocyclic compounds, compositions and medicinal applications thereof (2017-01-24),

5. 9340506 - Acetamide derivatives as glucokinase activators, their process and medicinal applications (2016-05-17),

6. 9284316 - Substituted fused pyrimidine compounds (2016-03-15),

7. 9233983 - Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof (2016-01-12),

8. 9193698 - Process for preparing fluoxastrobin (2015-11-24),

9. 9115133 - Substituted fused tricyclic compounds, compositions and medicinal applications thereof (2015-08-25),

10. 9006177 - Fused tricyclic compounds as adenosine receptor antagonist (2015-04-14),

11. 8940900 - 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application (2015-01-27),

12. 8940751 - Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications (2015-01-27),

13. 8859566 - Substituted fused pyrimidine compounds (2014-10-14),

14. 8796290 - Substituted fused pyrimidine compounds, its preparation and uses thereof (2014-08-05),

15. 8501955 - Acetamide derivatives as glucokinase activators, their process and medicinal application (2013-08-06),

Company Overview

Advinus Therapeutics Private Limited is a biotechnology company based in Bengaluru, India, specializing in drug discovery and development. The organization focuses on innovative therapeutic solutions across various therapeutic areas, including oncology, metabolic disorders, and infectious diseases. With a commitment to advancing healthcare, Advinus employs cutting-edge research methodologies and technologies to create effective treatments, aiming to address unmet medical needs both locally and globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#24 in Bengaluru

#126 in India

#39,921 in the World

Bengaluru, India

Advinus Therapeutics Private Limited

Forward Citations = 85

54 inventors:

Dinesh Barawkar (7 out of 10 patents)

Debnath Bhuniya (6 out of 15 patents)

Kasim A Mookhtiar (6 out of 6 patents)

4. Yogesh Waman (6 out of 7 patents)

5. Sujay Basu (6 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Advinus Therapeutics Private Limited. Retrieved from https://idiyas.com/company/advinus-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…